NRAS and melanoma: To date, most of the studies of MAPK pathway activation have focused on mutational activation of the pathway, including that of BRAF, NRAS, and NF1. As melanomas are felt to be “addicted” to MAPK pathway activation, identifying alternative mechanisms of MAPK pathway activation is noteworthy given its potential to contribute to our understanding of melanoma initiation.